Cargando…
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study
BACKGROUND: The rate of seroconversion after COVID-19 vaccination in patients with moderate to severe psoriasis requiring systemic treatment is poorly understood. OBJECTIVES: The aim of this prospective single-center cohort study performed between May 2020 and October 2021 was to determine the rate...
Autores principales: | Lodde, Georg Christian, Krefting, Frederik, Placke, Jan-Malte, Schneider, Lea, Fiedler, Melanie, Dittmer, Ulf, Becker, Jürgen Christian, Hölsken, Stefanie, Schadendorf, Dirk, Ugurel, Selma, Sondermann, Wiebke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061348/ https://www.ncbi.nlm.nih.gov/pubmed/37006279 http://dx.doi.org/10.3389/fimmu.2023.1107438 |
Ejemplares similares
-
COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates
por: Lodde, Georg C., et al.
Publicado: (2022) -
Common Fundamentals of Psoriasis and Depression
por: HÖLSKEN, Stefanie, et al.
Publicado: (2021) -
Expectation-induced enhancement of pain, itch and quality of life in psoriasis patients: study protocol of a randomised controlled trial
por: Hölsken, Stefanie, et al.
Publicado: (2021) -
Randomisierte klinische Studie zur Kompressionstherapie der Unterschenkel bei Patienten mit Psoriasis
por: Krefting, Frederik, et al.
Publicado: (2023) -
Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
por: Thielmann, Carl Maximilian, et al.
Publicado: (2022)